Latest news May 21, 2026 Eli Lilly and Co reports up to 28.3% weight loss in pivotal phase 3 TRIUMPH-1 trial Retatrutide met the primary and key secondary endpoints for obesity at 80 weeks across all retatrutide doses (4 mg, 9 mg, and 12 mg), delivering clinically meaningful weight loss
Slow down when eating
Its often called the stress hormone because it is released in response to stress
They are also believed to increase leptin sensitivity, as determined by decreased leptin levels in non-diabetic women with obesity who lost weight on exenatide
However, Saxenda (liraglutide) and Wegovy (semaglutide) are approved as weight loss medications for certain children aged 12 years and older with obesity
Eat smaller, more frequent meals, avoid high-fat foods, and increase fibre intake gradually